These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7557835)

  • 1. Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family.
    Malaisse WJ
    Horm Metab Res; 1995 Jun; 27(6):263-6. PubMed ID: 7557835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.
    Louchami K; Jijakli H; Sener A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):155-68. PubMed ID: 9583090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):81-7. PubMed ID: 7671557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meglitinide analogs: new insulinotropic agents for the treatment of non-insulin dependent diabetes].
    Malaisse WJ
    Rev Med Brux; 2003 Jun; 24(3):162-8. PubMed ID: 12891883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues.
    Jijakli H; Ulusoy S; Malaisse WJ
    Pharmacol Res; 1996; 34(3-4):105-8. PubMed ID: 9051699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of a new class of insulin secretagogues.
    Malaisse WJ
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S140-3. PubMed ID: 10522840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
    Malaisse WJ
    Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
    Malaisse WJ
    Treat Endocrinol; 2003; 2(6):401-14. PubMed ID: 15981944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
    Ichikawa K; Yamato T; Tsuji A; Ojima K; Kusama H; Kojima M
    Arzneimittelforschung; 2002; 52(8):605-9. PubMed ID: 12236048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New esters of succinic acid and mixed molecules formed by such esters and a meglitinide analog: study of their insulinotropic potential.
    Laghmich A; Ladrière L; Dannacher H; Björkling F; Malaisse WJ
    Pharmacol Res; 2000 May; 41(5):543-54. PubMed ID: 10753554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the methyl esters of pyruvate, succinate and glutamate on the secretory response to meglitinide analogues in rat pancreatic islets.
    Bakkali Nadi A; Zhang TM; Malaisse WJ
    Pharmacol Res; 1996 Mar; 33(3):191-4. PubMed ID: 8880890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionophoretic activity of meglitinide analogues.
    Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ
    Diabetes Res; 1994; 27(2):61-71. PubMed ID: 7671555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256.
    Mori K; Takasaki K; Katoh Y; Yano H; Ueno K; Ichimura M; Kusaka H; Nomoto Y; Higo K; Nakanishi S
    Eur J Pharmacol; 2005 Dec; 528(1-3):176-82. PubMed ID: 16316644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of insulin and somatostatin release by two meglitinide analogs.
    Leclercq-Meyer V; Ladrière L; Fuhlendorff J; Malaisse WJ
    Endocrine; 1997 Dec; 7(3):311-7. PubMed ID: 9657067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
    Lins L; Brasseur R; Malaisse WJ
    Biochem Pharmacol; 1995 Nov; 50(11):1879-84. PubMed ID: 8615868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
    Ohnota H; Kobayashi M; Koizumi T; Katsuno K; Sato F; Aizawa T
    Biochem Pharmacol; 1995 Jan; 49(2):165-71. PubMed ID: 7840793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
    Best L; Benington S
    Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas.
    Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinotropic action of the monoethyl ester of succinic acid.
    Ladrière L; Louchami K; Viñambres C; Kadiata MM; Jijakli H; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
    Gen Pharmacol; 1998 Sep; 31(3):377-83. PubMed ID: 9703205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.